Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Double trichophytic closure effectively repairs thin scalp scars, reducing financial burden.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Improved hair loss treatment using special particles and surfactants.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.